CRISPR Therapeutics AG Common Shares

formerly CRISPR TherapeuticsIPO

Home | CRISPR Therapeutics

Public · Zug, Switzerland · Founded 2013 · $604.5M raised

Headquarters
Zug
Employees
201–500
Founded
2013
Business Model
B2B
Total Funding
$604.5M
Last Round
$280.0M Venture RoundFeb 2024
Rounds
8
Type
Public

About

CRISPR Therapeutics is a clinical-stage gene editing company in Zug, Switzerland, founded 2013 by Emmanuelle Charpentier. CTX001 (exa-cel) approved for sickle cell and beta thalassemia.

Summary

CRISPR Therapeutics AG Common Shares is a Biotech company based in Zug, Switzerland, founded in 2013. It has raised $604.5M in total across 8 rounds, most recently a $280.0M Venture Round round in Feb 2024. Investors include SR One, Bayer AG and Jerel Davis.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundFeb 2024
$280.0M

Sign up to see all 9 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CRISPR Therapeutics AG Common Shares on Indexed.vc
<a href="https://indexed.vc/companies/crispr-therapeutics-ag-common-shares"><img src="https://indexed.vc/api/badge/company/crispr-therapeutics-ag-common-shares" alt="CRISPR Therapeutics AG Common Shares on Indexed.vc" width="260" height="76" /></a>